Medical isotope firm IsoRay said it has promoted its controller, Jonathan Hunt, to the position of chief financial officer (CFO).
Hunt succeeds Michael Dunlop, who is considering a new position as vice president of planning and facilities with responsibility for opening and managing IsoRay's new manufacturing facilities in Idaho, according to the Richland, WA-based company.
In other news, the company said that effective October 1 this year, the price for its cesium-131 brachytherapy seeds will increase from $55 to $59 per seed.
By AuntMinnie.com staff writers
September 12, 2006
Related Reading
IsoRay revenues surge, loss widens in 2006, September 6, 2006
IsoRay raises $5 million, August 18, 2006
IsoRay begins cesium-131 production testing
IsoRay forecasts record seed orders, June 20, 2006
IsoRay names Hunt as controller, April 19, 2006
Copyright © 2006 AuntMinnie.com
